Market Forecast By Product Type (Drug-Eluting Stent, Bare Metal Coronary Stent, Bioabsorbable Stent), By Biomaterial (Metallic Biomaterial, Polymeric Biomaterial, Natural Biomaterial), By End-users (Hospitals, Ambulatory Surgical Centers) And Competitive Landscape
| Product Code: ETC7540909 | Publication Date: Sep 2024 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The India coronary stent market import shipment demonstrated robust growth with a CAGR of 29.8% from 2020 to 2024. The growth rate between 2023 and 2024 slightly moderated to 10.2%, indicating a stable expansion trend in the market during this period.

According to 6Wresearch internal database and industry insights
The India Coronary Stent Market report thoroughly covers the market by product type, biomaterial, and end-user sector. The report provides a detailed analysis of ongoing market trends, opportunities/high-growth areas, and market drivers, helping stakeholders devise and align their market strategies according to current and future market dynamics.
| Report Name | India Coronary Stent Market |
| Forecast Period | 2026–2032 |
| CAGR | 7.5% |
| Growing Sector | Hospitals |
Due to the surging cases of coronary artery diseases and better access to healthcare, the India Coronary Stent Industry is gaining momentum. The technological advancements in stent designs further upscale product demand. Due to improved results in restenosis, the demand for drug-eluting stents are gaining special attention. The government initiatives further help in the enhancement of infrastructure and providing healthcare solutions that are affordable, boosting the need for coronary stents in the country.
Below are some prominent drivers and their influence on the market dynamics:
| Drivers | Primary Segments Affected | Why It Matters |
| Rising Cardiovascular Diseases | By End-Use Sector (Hospitals) | More heart diseases raise stent demand. |
| Technological Advancements | By Product Type (Drug-Eluting Stent, Bare Metal Stent) | New stents improve outcomes and prevent restenosis. |
| Government Health Programs | By End-Use Sector (Ambulatory Surgical Centers, Hospitals) | Affordable healthcare boosts stent access. |
| Rising Awareness of Heart Health | By End-Use Sector (Hospitals, Ambulatory Surgical Centers) | More awareness allow people to go for surgeries. |
| Improved Stent Materials | By Biomaterial (Metallic Biomaterial, Polymeric Biomaterial) | Better materials make stents more effective. |
The India Coronary Stent Market Size is projected to grow at a robust pace, with a CAGR of 7.5% during the forecast period of 2026–2032. There are several factors influencing the growth of the market. One major factor is the surge in the number of incidences of cardiovascular diseases. This is a key driver propelling the requirement for coronary stent procedures across hospitals and surgical centers. In addition to this, advancements in technology has given rise to better stent designs, that offer better clinical outcomes, thus increasing their usage, and this is especially beneficial in the case of drug-eluting stents. Moreover, now healthcare is accessible to a wider patient population due to government programs emphasizing on better healthcare access that is also affordable, so that patients can access these life-saving treatments, without burning a hole in their pocket.
Below are some prominent restraints and their influence on the market dynamics:
| Restraints | Primary Segments Affected | What This Means |
| High Cost of Advanced Stents | By Product Type (Drug-Eluting Stent) | High cost may limit the adoption of advanced stent technologies. |
| Limited Access in Rural Areas | By End-Use Sector (Ambulatory Surgical Centers) | Lack of infrastructure and access to skilled professionals in rural regions may impede growth. |
| Regulatory Challenges | By Biomaterial (Metallic Biomaterial) | Long approval procedures for new stent materials and technologies. |
| Risk of Complications | By End-Use Sector (Hospitals) | Patient concerns regarding potential stent-related complications can limit adoption. |
The cost of advanced stents is high, which is a key factor in restricting its adoption, especially in rural regions. There are regulatory hurdles that the market encounters in the approval process of new stent designs. The rising government initiatives focus at improving the healthcare accessibility and affordability, along with this, the advancements in manufacturing processes and material efficiency are all factors likely to help in overcoming these hurdles as they will reduce the cost of stents.
Some major trends contributing to the India Coronary Stent Market growth are:
Some investment opportunities that will shape the dynamics of the India Coronary Stent Market include:
Below is the list of prominent companies leading the India Coronary Stent Market:
| Company Name | Boston Scientific Corporation |
|---|---|
| Established Year | 1979 |
| Headquarters | Marlborough, Massachusetts, USA |
| Official Website | Click Here |
Boston Scientific is a global leader in medical devices, including coronary stents, offering innovative products in the drug-eluting and bioabsorbable stent categories.
| Company Name | Medtronic PLC |
|---|---|
| Established Year | 1949 |
| Headquarters | Dublin, Ireland |
| Official Website | Click Here |
Medtronic manufactures a wide range of coronary stents, including drug-eluting and balloon-expandable stents, and focuses on advancing cardiovascular treatments through technology.
| Company Name | Abbott Laboratories |
|---|---|
| Established Year | 1888 |
| Headquarters | Abbott Park, Illinois, USA |
| Official Website | Click Here |
Abbott provides leading-edge coronary stents and related devices, with a focus on improving the treatment of coronary artery disease through innovation.
| Company Name | Terumo Corporation |
|---|---|
| Established Year | 1921 |
| Headquarters | Tokyo, Japan |
| Official Website | Click Here |
Terumo specializes in medical devices and offers a range of coronary stents designed to meet the needs of both emerging and advanced markets globally.
| Company Name | Cook Medical |
|---|---|
| Established Year | 1963 |
| Headquarters | Bloomington, Indiana, USA |
| Official Website | Click Here |
Cook Medical provides innovative medical solutions, including coronary stents, and is focused on advancing minimally invasive procedures in cardiovascular healthcare.
According to Indian Government Data, government regulations focus on improving the quality and safety of coronary stents while ensuring affordable treatment availability. There are programs that support the adoption of advanced stent technologies and subsidized healthcare initiatives, and these measures are being implemented to enhance access. Some key government initiatives are National Health Mission, which enhances access to treatments in rural areas, and the Ayushman Bharat Scheme, providing subsidized stents for economically disadvantaged patients.
The India Coronary Stent Market Share is expected to rise firmly, supported by increasing cardiovascular health awareness, advancements in stent technology, and expanding healthcare infrastructure. The demand for drug-eluting stents will continue to rise due to their better clinical outcomes. Government initiatives focused on increasing access to stent procedures will further propel market growth. In addition, the growing usage of minimally invasive surgical techniques will further generate the demand for coronary stents.
The report offers a comprehensive study of the following market segments and their leading categories:
According to Rashika, Senior Research Analyst, 6Wresearch, the market will be dominated by drug-eluting stents according to product type as these stents deliver medication which prevents artery blockage and provides better performance than bare metal stents.
The market will be dominated by metallic biomaterials as stainless steel and cobalt-chromium alloys have been proven to meet the requirements for making coronary stents while offering strength and compatibility with human tissue.
Hospitals will dominate the end-user sector due to its advanced medical infrastructure and the power to handle complex coronary stent procedures, providing comprehensive care to patients.
The report provides a detailed analysis of the following market segments and subsegments:
| 1 Executive Summary |
| 2 Introduction |
| 2.1 Key Highlights of the Report |
| 2.2 Report Description |
| 2.3 Market Scope & Segmentation |
| 2.4 Research Methodology |
| 2.5 Assumptions |
| 3 India Coronary Stent Market Overview |
| 3.1 India Country Macro Economic Indicators |
| 3.2 India Coronary Stent Market Revenues & Volume, 2022 & 2032F |
| 3.3 India Coronary Stent Market - Industry Life Cycle |
| 3.4 India Coronary Stent Market - Porter's Five Forces |
| 3.5 India Coronary Stent Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
| 3.6 India Coronary Stent Market Revenues & Volume Share, By Biomaterial, 2022 & 2032F |
| 3.7 India Coronary Stent Market Revenues & Volume Share, By End-users, 2022 & 2032F |
| 4 India Coronary Stent Market Dynamics |
| 4.1 Impact Analysis |
| 4.2 Market Drivers |
| 4.2.1 Increasing prevalence of cardiovascular diseases in India |
| 4.2.2 Growing adoption of minimally invasive surgeries |
| 4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in India |
| 4.3 Market Restraints |
| 4.3.1 Stringent regulatory requirements for approval of coronary stents |
| 4.3.2 High cost associated with coronary stent procedures |
| 4.3.3 Lack of awareness about advanced treatment options among patients |
| 5 India Coronary Stent Market Trends |
| 6 India Coronary Stent Market, By Types |
| 6.1 India Coronary Stent Market, By Product Type |
| 6.1.1 Overview and Analysis |
| 6.1.2 India Coronary Stent Market Revenues & Volume, By Product Type, 2022- 2032F |
| 6.1.3 India Coronary Stent Market Revenues & Volume, By Drug-Eluting Stent, 2022- 2032F |
| 6.1.4 India Coronary Stent Market Revenues & Volume, By Bare Metal Coronary Stent, 2022- 2032F |
| 6.1.5 India Coronary Stent Market Revenues & Volume, By Bioabsorbable Stent, 2022- 2032F |
| 6.2 India Coronary Stent Market, By Biomaterial |
| 6.2.1 Overview and Analysis |
| 6.2.2 India Coronary Stent Market Revenues & Volume, By Metallic Biomaterial, 2022- 2032F |
| 6.2.3 India Coronary Stent Market Revenues & Volume, By Polymeric Biomaterial, 2022- 2032F |
| 6.2.4 India Coronary Stent Market Revenues & Volume, By Natural Biomaterial, 2022- 2032F |
| 6.3 India Coronary Stent Market, By End-users |
| 6.3.1 Overview and Analysis |
| 6.3.2 India Coronary Stent Market Revenues & Volume, By Hospitals, 2022- 2032F |
| 6.3.3 India Coronary Stent Market Revenues & Volume, By Ambulatory Surgical Centers, 2022- 2032F |
| 7 India Coronary Stent Market Import-Export Trade Statistics |
| 7.1 India Coronary Stent Market Export to Major Countries |
| 7.2 India Coronary Stent Market Imports from Major Countries |
| 8 India Coronary Stent Market Key Performance Indicators |
| 8.1 Average waiting time for coronary stent procedures |
| 8.2 Percentage of hospitals offering advanced coronary stent technologies |
| 8.3 Number of training programs for healthcare professionals on coronary stent implantation techniques |
| 9 India Coronary Stent Market - Opportunity Assessment |
| 9.1 India Coronary Stent Market Opportunity Assessment, By Product Type, 2022 & 2032F |
| 9.2 India Coronary Stent Market Opportunity Assessment, By Biomaterial, 2022 & 2032F |
| 9.3 India Coronary Stent Market Opportunity Assessment, By End-users, 2022 & 2032F |
| 10 India Coronary Stent Market - Competitive Landscape |
| 10.1 India Coronary Stent Market Revenue Share, By Companies, 2025 |
| 10.2 India Coronary Stent Market Competitive Benchmarking, By Operating and Technical Parameters |
| 11 Company Profiles |
| 12 Recommendations |
| 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here